HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Fiduxosin

HCID 172307
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
208993-54-8
Standard SMILES
COc1cccc2c1[C@@H]1CN(CCCCn3c(=O)[nH]c4c(sc5ncc(-c6ccccc6)nc54)c3=O)C[C@@H]1CO2
InChIKey
WDTAYDBPNYFWDR-WOJBJXKFSA-N
Molecular formula
C30H29N5O4S
Average molar mass
555.6 g/mol
Monoisotopic mass
555.1940256

Overview

Fiduxosin is a small molecule drug. Fiduxosin has a monoisotopic molecular weight of 555.19 Da.

Names & identifiers

Preferred name
Fiduxosin
IUPAC
5-[4-[(3aR,9bR)-9-methoxy-3,3a,4,9b-tetrahydro-1H-chromeno[3,4-c]pyrrol-2-yl]butyl]-12-phenyl-8-thia-3,5,10,13-tetrazatricyclo[7.4.0.02,7]trideca-1(13),2(7),9,11-tetraene-4,6-dione
English name
Fiduxosin
Molecular formula
C30H29N5O4S
Molecular weight
555.65

Names & synonyms

Fiduxosin208993-54-8fiduxosinafiduxosineW9O92HYT6IA-1859801 (FREE BASE)ABT980DTXSID4010171633-(4-(9-Methoxy-1,2,3,3a,4,9b-hexahydro(1)benzopyran(3,4-c)pyrrol-2-yl)butyl)-8-phenylpyrazino(2',3'-4,5)thieno(3,2-d)pyrimidine-2,4(1H,3H)-dionefiduxosinumRefChem:140419DTXCID201475351
Show more names
3-[4-[(3aR,9bR)-9-methoxy-3,3a,4,9b-tetrahydro-1H-chromeno[3,4-c]pyrrol-2-yl]butyl]-8-phenyl-1H-pyrazino[1,2]thieno[3,4-b]pyrimidine-2,4-dionePyrazino[2',3':4,5]thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione, 8-phenyl-3-[4-[(3aR,9bR)-1,3a,4,9b-tetrahydro-9-methoxy[1]benzopyrano[3,4-c]pyrrol-2(3H)-yl]butyl]-
Fiduxosin [INN]5-[4-[(3aR,9bR)-9-methoxy-3,3a,4,9b-tetrahydro-1H-chromeno[3,4-c]pyrrol-2-yl]butyl]-12-phenyl-8-thia-3,5,10,13-tetrazatricyclo[7.4.0.02,7]trideca-1(13),2(7),9,11-tetraene-4,6-dione8-Phenyl-3-(4-((3aR,9bR)-1,3a,4,9b-tetrahydro-9-methoxy(1)benzopyrano(3,4-c)pyrrol-2(3H)-yl)butyl)pyrazino(2',3':4,5)thieno(3,2-d)pyrimidine-2,4(1H,3H)-dioneMLS002153379Fiduxosin free baseNCGC00162178-02SMR001230768208993-54-8 (free base)

Properties

Computed structural propertiesFilling in

XLogP
4.2
Topological polar surface area
125 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
8
Rotatable bonds
7
Heavy atoms
40
Formal charge
0
Complexity
936

Physicochemical properties

Density
1.339 · 1.339±0.06 g/cm3(Predicted)
storage temp.
-20 °C · Store at -20°C
solubility
Soluble in DMSO
pka
8.4 · 8.40±0.20(Predicted)
FDA UNII
9 O92HYT6I · W9O92HYT6I

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Toxicology

Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Fiduxosin

vMost-DILI-concern

8

Discontinued

DOI:10.1016/j.drudis.2016.02.015

Chemistry & industry

Applications

UsesFiduxosin is a novel α1a-adrenoceptor antagonist that may be used for the treatment of benign prostatic hyperplasia. (Abbot Labs)

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
208993-54-8
PubChem CID
172307
DTXSID
DTXSID401017163
ChEMBL
CHEMBL1256183
UNII
W9O92HYT6I
Nikkaji
J1.698.472H